Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DCGO 
DocGo Inc (DCGO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/30/2025: DCGO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.08
1 Year Target Price $3.08
| 3 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -41.26% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 102.70M USD | Price to earnings Ratio - | 1Y Target Price 3.08 |
Price to earnings Ratio - | 1Y Target Price 3.08 | ||
Volume (30-day avg) 7 | Beta 0.95 | 52 Weeks Range 1.03 - 5.67 | Updated Date 10/31/2025 |
52 Weeks Range 1.03 - 5.67 | Updated Date 10/31/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.2% | Operating Margin (TTM) -21.74% |
Management Effectiveness
Return on Assets (TTM) -4.02% | Return on Equity (TTM) -9.07% |
Valuation
Trailing PE - | Forward PE 60.24 | Enterprise Value 81482617 | Price to Sales(TTM) 0.24 |
Enterprise Value 81482617 | Price to Sales(TTM) 0.24 | ||
Enterprise Value to Revenue 0.19 | Enterprise Value to EBITDA 5.57 | Shares Outstanding 97808137 | Shares Floating 85699490 |
Shares Outstanding 97808137 | Shares Floating 85699490 | ||
Percent Insiders 7.31 | Percent Institutions 52.33 |
Upturn AI SWOT
DocGo Inc
Company Overview
History and Background
DocGo Inc. was founded in 2015. It provides mobile health and remote patient monitoring services. The company went public through a SPAC merger in 2021.
Core Business Areas
- Mobile Health: Provision of healthcare services at patients' locations including testing, vaccinations, and urgent care.
- Remote Patient Monitoring: Utilizing technology to monitor patients' health conditions remotely.
Leadership and Structure
Anthony Capone serves as the CEO. The company has a board of directors overseeing the overall strategy and operations.
Top Products and Market Share
Key Offerings
- Mobile Medical Services: On-demand medical services delivered directly to patients. Market share data for mobile medical services is fragmented, but DocGo is a significant player in the markets it serves. Competitors include DispatchHealth, CityMD (now part of VillageMD), and numerous regional providers. Revenue estimated at 80% of total revenue.
- Remote Patient Monitoring Solutions: Technology-enabled remote monitoring of patient vitals and health data. The remote patient monitoring market is growing rapidly. Exact market share data is not readily available. Competitors include BioTelemetry, Teladoc Health (TDOC), and Omron Healthcare. Revenue estimated at 20% of total revenue.
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards more convenient and accessible care delivery models, with increasing adoption of telehealth and mobile health services.
Positioning
DocGo is positioned as a technology-enabled healthcare provider focused on mobile health and remote patient monitoring. Its competitive advantages include its proprietary technology platform and its ability to provide on-demand medical services.
Total Addressable Market (TAM)
The TAM for mobile health and remote patient monitoring is estimated to be in the billions of dollars. DocGo is positioned to capture a portion of this market with its established presence and technology platform.
Upturn SWOT Analysis
Strengths
- Proprietary technology platform
- Mobile health service delivery capabilities
- Experienced management team
- Strong growth in revenue
Weaknesses
- Dependence on key contracts
- Relatively small market capitalization
- Profitability concerns
- Negative public sentiment surrounding business practices
Opportunities
- Expansion into new geographic markets
- Increasing adoption of telehealth and mobile health services
- Strategic partnerships with healthcare providers and payers
- Growth in remote patient monitoring market
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Negative publicity
Competitors and Market Share
Key Competitors
- TDOC
- AMN
- HQY
Competitive Landscape
DocGo competes with larger, more established players in the telehealth and staffing sectors. Its focus on mobile health provides a differentiated offering, but it faces challenges in scaling and maintaining profitability.
Major Acquisitions
Ambulnz
- Year: 2021
- Acquisition Price (USD millions): 24.5
- Strategic Rationale: Expanded DocGo's ambulance transportation capabilities and market reach.
Growth Trajectory and Initiatives
Historical Growth: DocGo has experienced rapid revenue growth in recent years.
Future Projections: Analyst estimates project continued revenue growth, driven by increasing demand for mobile health and remote patient monitoring services.
Recent Initiatives: Recent initiatives include expanding into new markets, launching new service offerings, and forming strategic partnerships.
Summary
DocGo shows promise in the mobile healthcare space with notable revenue growth, but profitability remains a key concern. Its expansion strategy and technology platform are strong points, though it faces intense competition and negative publicity. The company needs to manage costs effectively and maintain strong contract relationships to sustain its growth trajectory. While showing improving financials, it is still considered high risk for investment.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SEC), Investor presentations, Market research reports, Analyst reports.
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DocGo Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-05 | CEO & Director Mr. Lee Bienstock | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3404 | Website https://www.docgo.com |
Full time employees 3404 | Website https://www.docgo.com | ||
DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.